Keywords: واکسن سرطانی; Cancer vaccine; Humanized mouse; B cell function; Immune checkpoint;
مقالات ISI واکسن سرطانی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن سرطانی; Breast cancer; Immunotherapy; Cancer vaccine; Immune checkpoint blockade; Adoptive cell transfer; Chemotherapy; Radiotherapy;
Keywords: واکسن سرطانی; FDA; US Food and Drug Administration; BCG; Calmette and Guerin; DC; dendritic cell; APCs; antigen-presenting cells; TSAs; tumor specific antigens; TRA; tumor rejection antigen; gp96; glycoprotein of 96â¯kDa; CTLs; cytotoxic T cells; SEREX; serological an
Keywords: واکسن سرطانی; Aluminum adjuvant; Glucan particle; Th1-biased immune response; Cytotoxic T lymphocyte; Dendritic cell; Cancer vaccine;
Keywords: واکسن سرطانی; Cancer vaccine; Nanoparticle vaccine; Sustained release antigen; Nanomedicine; Thioether linker; Disulfide linker;
Keywords: واکسن سرطانی; Cancer vaccine; Mesoporous silicon microparticles; Melanoma immunotherapy; Dual TLR signaling; TRP2 peptide;
Keywords: واکسن سرطانی; HCC; cancer vaccine; HEPAVAC; HLA-ligandome; HCC; hepatocellular carcinoma; ASR; age-standardized rate; HBV; hepatitis B virus; HCV; hepatitisC virus; TAAs; Tumor-associated antigens; DAMPs; damage-associated molecular patterns; DCs; dendritic cells; AFP;
Keywords: واکسن سرطانی; CSC; cancer stem cell; CTC; circulating tumor cell; EMT; epithelial-mesenchymal transition; HTS; high-throughput screening; MET; mesenchymal-epithelial transition; Epithelial-mesenchymal transition; Brachyury; Cancer vaccine; Stemness;
Keywords: واکسن سرطانی; TIL; IL-2; Interferon; Anti-PD-1; Anti-PD-L1; Cancer vaccine;
Keywords: واکسن سرطانی; Animal model; Transgenic mouse; Domestic cat; Cancer vaccine; DNA vaccine; HER2/neu; Cancer imaging; Tumor ablation; In situ immunization;
Keywords: واکسن سرطانی; Cancer vaccine; Trial design; End points; Immunotherapy;
Keywords: واکسن سرطانی; Cancer vaccine; Prostatic neoplasm; Radiation effects; Radiotherapy;
Keywords: واکسن سرطانی; Poly(4,4â²-trimethylenedipiperdyl sulfide); Cancer vaccine; Microparticles; PNSN; Nanoparticles, biodegradable polymer, antigen; CpG, PLGA;
Keywords: واکسن سرطانی; Nanogel; Cancer vaccine; Cytokine delivery; Nasal vaccine; siRNA delivery;
Keywords: واکسن سرطانی; Cancer vaccine; Nanoparticles; PLGA; Mannose receptor targeting; TLR; Antigen presenting cells; Melanoma
Keywords: واکسن سرطانی; Cancer Immunology; Cancer immunotherapy; Monoclonal antibody; Cancer vaccine; History of immunology; Combination treatment;
Keywords: واکسن سرطانی; Comparability studies; Monoclonal antibody; Cancer vaccine; Mass spectrometry;
Keywords: واکسن سرطانی; Exosomes; immunotherapy; cancer vaccine; theranostics; nanoparticles; nanomedicine;
Keywords: واکسن سرطانی; Hepatocellular carcinoma; Active immunotherapy; Cancer vaccine; Tumor antigen discovery; Metronomic chemotherapy;
Keywords: واکسن سرطانی; Biological delivery system; Cancer vaccine; Viral vectors; Bacterial vectors; DC vaccine and MSCs-based delivery system;
ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen
Keywords: واکسن سرطانی; Cancer vaccine; Adenoviral vectors; Inducible T cell costimulatory (ICOS) ligand; T helper 17 cells (Th17); MUC1;
Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses
Keywords: واکسن سرطانی; Nanoparticle; Cancer-testis antigen (CT); NY-ESO-1; MAGE-A3; HLA-A2; Cancer vaccine;
Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect
Keywords: واکسن سرطانی; Soluble PD-1; Cancer vaccine; MUC1; Survivin; Anti-tumor immunity;
Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer
Keywords: واکسن سرطانی; Cancer vaccine; Cytotoxic T cells; Melanoma; Breast cancer; Tumor-infiltrating lymphocytes;
Two tandem repeats of mHSP70407-426 enhance therapeutic antitumor effects of a recombined vascular endothelial growth factor (VEGF) protein vaccine
Keywords: واکسن سرطانی; mHSP70407-426; VEGF; Cancer vaccine; Anti-angiogenesis; Cancer immunotherapy;
Transdermal immunomodulation: Principles, advances and perspectives
Keywords: واکسن سرطانی; AD; atopic dermatitis; AHR; airway hyper responsiveness; APCs; antigen-presenting cells; AS-ODN; antisense oligonucleotide; BCG; Bacillus Calmette-Guérin; CTLs; cytotoxic T cells; dDCs; dermal dendritic cells; DfE; Dermatophagoides farinae extract; EAE;
Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy
Keywords: واکسن سرطانی; Immunotherapy; Cancer vaccine; Nanoparticle; TLR7/8 agonist;
A short hairpin RNA-based adjuvant targeting NF-κB repressor IκBα promotes migration of dermal dendritic cells to draining lymph nodes and antitumor CTL responses induced by DNA vaccination
Keywords: واکسن سرطانی; DNA vaccine; Genetic adjuvant; Dendritic cell; Cancer vaccine; NFκB inhibitor; IκBα;
Personalized cancer vaccines: Targeting the cancer mutanome
Keywords: واکسن سرطانی; Personalized; Cancer vaccine; Genome sequencing; Neoantigen;
Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors
Keywords: واکسن سرطانی; Modified vaccinia virus Ankara; Toll-like receptor; Cancer vaccine; Innate immunity; Macrophages; IL-18;
Plant viral nanoparticles-based HER2 vaccine: Immune response influenced by differential transport, localization and cellular interactions of particulate carriers
Keywords: واکسن سرطانی; Cancer vaccine; Viral nanoparticles; HER2; Antigen delivery; Peptide vaccine;
ReviewNanomaterials for cancer immunotherapy
Keywords: واکسن سرطانی; Nanomaterials; Cancer immunotherapy; Cancer vaccine; Tumor microenvironment;
Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
Keywords: واکسن سرطانی; AAH; atypical adenomatous hyperplasia; AK; actinic keratosis; AML; acute myelogenous leukemia; AMM; asymptomatic multiple myeloma; APC; antigen presenting cell; B-ALL; B cell acute lymphocytic leukemia; B-CLL; B cell chronic lymphocytic leukemia; BD; Bowe
Development and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine
Keywords: واکسن سرطانی; vaccine adjuvants; cancer vaccine; PET lipid A;
Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses
Keywords: واکسن سرطانی; Pattern recognition receptors; Toll-like receptors; Adjuvant; Adaptive immunity; Cancer vaccine; Hepatitis B virus; CpG; FNIII EDA;
MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model
Keywords: واکسن سرطانی; MUC1; Survivin; DNA prime-rAd boost; IL-2 adjuvant; Cancer vaccine;
Recent advances in the development of nanomaterials for DC-based immunotherapy
Keywords: واکسن سرطانی; Dendritic cells; Immunotherapy; Cancer vaccine; Tracking; Nanomaterials;
Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8+ T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells
Keywords: واکسن سرطانی; Adjuvant; Glycolipid; NKT cells; CD1d; TLR4; Malaria vaccine; Cancer vaccine; WT-1; Circumsporozoite protein; Memory-like effector NKT cells;
Research paperImprovement of anti-tumor immunity of fibroblast activation protein α based vaccines by combination with cyclophosphamide in a murine model of breast cancer
Keywords: واکسن سرطانی; Fibroblast activation protein α; Prime-boost strategy; Cyclophosphamide; Immunosuppression; Cancer vaccine;
Enhancement of fibroblast activation protein α-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice
Keywords: واکسن سرطانی; Fibroblast activation protein α; Interleukin-10; Cyclophosphamide; Prime-boost strategy; Immunosuppression; Cancer vaccine; Ad; adenovirus; CAFs; cancer-associated fibroblasts; CpVR-FAP; a recombinant plasmid encoding human FAPα; CY; cyclophosphamide; E
Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA
Keywords: واکسن سرطانی; Exosomes; Genetic engineering; Tumor antigens; CpG DNA; Cancer vaccine; Drug delivery;
Photosensitisation facilitates cross-priming of adjuvant-free protein vaccines and stimulation of tumour-suppressing CD8 T cells
Keywords: واکسن سرطانی; Antigen delivery; Cytosol targeting; Cancer vaccine; Photosensitization
Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs
Keywords: واکسن سرطانی; Cancer vaccine; Peptide vaccine; CpG-ODN; Antigen presenting cell; β-Glucan;
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer
Keywords: واکسن سرطانی; Non-small cell lung cancer; Cancer vaccine; Cancer immunotherapy; Cancer gene therapy; TGF-β;
A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model
Keywords: واکسن سرطانی; CD40L; Dendritic cell; Cancer vaccine; DNA vaccine; Surfactant protein D; B16-F10 melanoma; ALS; analytical light scattering; APC; antigen presenting cell; BMDC; bone marrow derived dendritic cells; CD40L; CD40 ligand; CTL; cytotoxic T lymphocytes; DC; de
Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs
Keywords: واکسن سرطانی; Poly(I:C); Poly-ICLC; Cancer vaccine; Adjuvant; TLR; Anti-tumor immunityAPC, antigen-presenting cells; CTL, cytotoxic T lymphocyte; DC, dendritic cell; dsRNA, double stranded RNA; IFN, interferon; MDA-5, melanoma differentiation-associated protein 5; NK,
High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine
Keywords: واکسن سرطانی; CT antigen; MAGE-A4; Cancer vaccine; Prognosis; MHC; Monitoring;
Polymer nanoparticles for enhanced immune response: Combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells
Keywords: واکسن سرطانی; Nanoparticles; Dendritic cells; Antigen delivery; SOCS1; Cancer vaccine;
CD4 T-cells transduced with CD80 and 4-1BBL mRNA induce long-term CD8 T-cell responses resulting in potent antitumor effects
Keywords: واکسن سرطانی; Cancer vaccine; CD4 T-cells; Costimulatory ligand; Tumor immunity;
Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine
Keywords: واکسن سرطانی; CTL; cytotoxic T lymphocytes; EBV-B; Epstein-Barr virus-transformed B; H/K-HELP; helper/killer-hybrid epitope long peptide; HPV; human papilloma virus; MMC; mitomycin C; Mo-DC; monocyte-derived dendritic cells; PBMC; peripheral blood mononuclear cells;